| 产品描述: | LY3020371 hydrochloride is a potent, selective metabotropic glutamate 2/3 receptor (mGlu2/3) antagonist with Ki of 5.3 and 2.5 nM, potently blocks cAMP formation with IC50 of 16.2 nM. LY3020371 hydrochloride exerts an antidepressant-like signature in vivo. |
| 靶点: |
mGluR2:5.3 nM (Ki);mGluR3:2.5 nM (Ki) |
| 体外研究: |
LY3020371 盐酸盐 (LY3020371.HCl) (静脉注射;3-15 mg/kg) 在大鼠中导致脑脊液药物水平有望有效阻断 mGlu2/3 受体[1]。 LY3020371盐酸盐 (LY3020371) (腹腔注射;3mg/kg、10mg/kg;2小时) 具有明显的促醒作用,导致 Wistar 大鼠在光照期的 NREM 睡眠大大减少[3]。 |
| 体内研究: |
LY3020371 盐酸盐 (LY3020371.HCl) 以高亲和力取代 mGlu2/3 激动剂配体[3H]-459477 的结合 (hmGlu2 Ki=5.26 nM;hmGlu3 Ki=2.50 nM)。 LY3020371 盐酸盐 (LY3020371.HCl) (0.1 nM-100 μM;1 小时) 有效阻断 mGlu2/3 激动剂 (DCG-IV) -抑制毛喉素刺激的 cAMP 形成 (IC50=16.2 nM),这种作用在表达 hmGlu3 的细胞中观察到类似的效果 (IC50=6.21 nM)。 LY3020371 盐酸盐 (LY3020371.HCl) 阻断激动剂抑制的自发 Ca2+ 振荡 (IC50 =34 nM) 和完整的海马切片制剂 (IC50=46 nM)。 |
| 参考文献: |
1. Witkin JM, et al. In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu2/3 receptor antagonist. Neuropharmacology. 2017 Mar 15;115:100-114. 2. Witkin JM, et al. Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects. Pharmacol Biochem Behav. 2017 Apr;155:43-55. 3. Wood CM, et al. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression. Neuropharmacology. 2018 Sep 15;140:246-259. |
| 保存条件: |
2-8°C, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.526 ml |
12.632 ml |
25.265 ml |
| 5 mM |
0.505 ml |
2.526 ml |
5.053 ml |
| 10 mM |
0.253 ml |
1.263 ml |
2.526 ml |
| 50 mM |
0.051 ml |
0.253 ml |
0.505 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |